F2 and autoimmune polyendocrinopathy: Since the prevalence of these aPS/PT Ab in seronegative APS patients is higher in the literature (23, 26), we believe that it would be of interest to increase the size of this subgroup of patients in our cohort to confirm the results of previous studies.